Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes

Nicotine and Tobacco Research

Volumn 14, Issue 11, 2012, Pages 1339-1345

  Kennett, Alexandra ^a   Heal, David J ^b   Wonnacott, Susan ^a  

^a University of Bath   (United Kingdom)

^b RenaSci Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR BETA2; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; AZETIDINES; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HIPPOCAMPUS; MALE; MICRODIALYSIS; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 84868088169     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts128     Document Type: Article

References (34)

1. Abin-Carriquiry, J. A., Voutilainen, M. H., Barik, J., Cassels, B. K., Iturriaga-Vásquez, P., Bermudez, I., et al. (2006). C3-halogenation of cytisine generates potent and effi cacious nicotinic receptor agonists. European Journal of Pharmacology, 536, 1-11. doi:10.1016/j.ejphar.2006.02.012
2. 3H]-norepinephrine from rat brain slices using a new 96-well format assay. Neuropharmacology, 39, 2663-2672. doi:10.1016/S0028-3908(00)00143-X
3. Arnsten, A. F. (2011). Catecholamine infl uences on dorsolateral prefrontal cortical networks. Biological Psychiatry, 69, e89-e99. doi:10.1016/j.biopsych.2011.01.027
4. Azam, L., Maskos, U., Changeux, J. P., Dowell, C. D., Christensen, S., De Biasi, M., et al. (2010). α -Conotoxin BuIA[T5A;P6O]: A novel ligand that discriminates between α 6ß4 and α 6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release. FASEB Journal, 24, 5113-5123. doi:10.1096/fj.10-166272
5. 3H]norepinephrine release from mouse hippocampal synaptosomes. Molecular Pharmacology, 70, 967-976. doi:10.1124/mol.106.024513
6. Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C., Eagle, D. M., et al. (2011). Prefrontal and monoaminergic contributions to stop-signal task performance in rats. Journal of Neuroscience, 31, 9254-9263. doi:10.1523/JNEUROSCI. 1543-11.2011
7. Barik, J., & Wonnacott, S. (2006). Indirect modulation by alpha7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: Interaction with glutamate and GABA systems and effect of nicotine withdrawal. Molecular Pharmacology, 69, 618-628. doi:10.1124/mol.105.018184
8. Belujon, P., & Grace, A. A. (2011). Hippocampus, amygdala, and stress: Interacting systems that affect susceptibility to addiction. Annals of the New York Academy of Sciences, 1216, 114-121. doi:10.1111/j.1749-6632.2010.05896.x
9. Brazell, M. P., Mitchell, S. N., & Gray, J. A. (1991). Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study. Neuropharmacology, 30, 823-833. Retrieved from http://www.journals.elsevier.com/neuropharmacology/
10. Carboni, E., & Silvagni, A. (2004). Dopamine reuptake by norepinephrine neurons: Exception or rule? Critical Reviews in Neurobiology, 16, 121-128. doi:10.1615/CritRevNeurobiol.v16.i12
11. 3H]-dopamine release. British Journal of Pharmacology, 117, 595-606. Retrieved from http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1476-5381
12. Gehricke, J. G., Loughlin, S. E., Whalen, C. K., Potkin, S. G., Fallon, J. H., Jamner, L. D., et al. (2007). Smoking to selfmedicate attentional and emotional dysfunctions. Nicotine & Tobacco Research, 9 (Suppl. 4), S523-S536. doi:10.1080/146222 00701685039
13. Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., et al. (2007). The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochemical Pharmacology, 74, 1235-1246. doi:10.1016/j.bcp.2007.07.032
14. Harvey, S. C., & Luetje, C. W. (1996). Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta subunits. Journal of Neuroscience, 16, 3798-3806. Retrieved from http://www.jneurosci.org/
15. 3H]dopamine release in rat striatal slices via glutamate release. Molecular Pharmacology, 58, 312-318. Retrieved from http://molpharm.aspetjournals.org
16. Koob, G. F. (2009). Brain stress systems in the amygdala and addiction. Brain Research, 1293, 61-75. doi:10.1016/j.brainres. 2009.03.038
17. Léna, C., de Kerchove D'Exaerde, A., Cordero-Erausquin, M., Le Novère, N., del Mar Arroyo-Jimenez, M., & Changeux, J. P. (1999). Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proceedings of the National Academy of Sciences U S A, 96, 12126-12131. doi: 10.1073/pnas.96.21.12126
18. 3H]norepinephrine from developing and adult rat hippocampus: Direct and indirect mechanisms. Neuropharmacology, 42, 653-661. doi:10.1016/S0028-3908(02)00019-9
19. Liu, X., Koren, A. O., Yee, S. K., Pechnick, R. N., Poland, R. E., & London, E. D. (2003). Self-administration of 5-iodo-A-85380, a beta2-selective nicotinic receptor ligand, by operantly trained rats. Neuroreport, 14, 1503-1505. doi:10.1097/01.wnr.0000085901. 20980.bd
20. Livingstone, P. D., Srinivasan, J., Kew, J. N., Dawson, L. A., Gotti, C., Moretti, M., et al. (2009). Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. European Journal of Neuroscience, 29, 539-550. doi:10.1111/j.1460-9568.2009. 06613.x
21. Livingstone, P. D., & Wonnacott, S. (2009). Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochememical Pharmacology, 78, 744-755. doi:10.1016/j.bcp. 2009.06.004
22. Luetje, C. W., & Patrick, J. (1991). Both alpha- and betasubunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. Journal of Neuroscience, 11, 837-845. Retrieved from http://www.jneurosci.org/content/11/3/837.long
23. Marshall, D. L., Redfern, P. H., & Wonnacott, S. (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. Journal of Neurochemistry, 68, 1511-1519. doi:10.1046/j.1471-4159. 1997.68041511.x
24. Millar, N. S., & Gotti, C. (2009). Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology, 56, 237-246. doi:10.1097/01.wnr.0000085901.20980.bd
25. Mogg, A. J., Jones, F. A., Pullar, I. A., Sharples, C. G., & Wonnacott, S. (2004). Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380. Neuropharmacology, 47, 848-859. doi:10.1016/j.neuropharm.2004.06.013
26. Mukhin, A. G., Gündisch, D., Horti, A. G., Koren, A. O., Tamagnan, G., Kimes, A. S., et al. (2000). 5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Molecular Pharmacology, 57, 642-649. Retrieved from http://molpharm.aspetjournals.org/content/57/3/642.long
27. Paxinos, G., & Watson, C. (1986). The rat brain in stereotaxic co-ordinates. Sydney: Academic Press.
28. Potter, A. S., Bucci, D. J., & Newhouse, P. A. (2011). Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity. Psychopharmacology (Berlin), 220, 331-340. doi: 10.1007/s00213-011-2476-0
29. Sacaan, A. I., Dunlop, J. L., & Lloyd, G. K. (1995). Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. Journal of Pharmacology and Experimental Therapeutics, 274, 224-230. Retrieved from http://jpet.aspetjournals.org/content/274/1/224.long
30. Scholze, P., Orr-Urtreger, A., Changeux, J. P., McIntosh, J. M., & Huck, S. (2007). Catecholamine outfl ow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation. British Journal of Pharmacology, 151, 414-422. doi:10.1038/sj.bjp.0707236
31. Summers, K. L., & Giacobini, E. (1995). Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochemical Research, 20, 753-759. Retrieved from http://www.springer.com/biomed/neuroscience/journal/11064
32. Williams, J. M., & Steketee, J. D. (2004). Characterization of dopamine transport in crude synaptosomes prepared from rat medial prefrontal cortex. Journal of Neuroscience Methods, 137, 161-165. doi:10.1016/j.jneumeth.2004.02.022
33. Wise, R. A. (1978). Catecholamine theories of reward: A critical review. Brain Research, 152, 215-247. doi:10.1016/0006-8993 (78)90253-6
34. Wonnacott, S. (1997). Presynaptic nicotinic ACh receptors. Trends in Neurosciences, 20, 92-98. doi:10.1016/S0166-2236 (96)10073-4